Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE: Safety Overview

Metric FOSAPREPITANT FOSAPREPITANT DIMEGLUMINE
Total FAERS Reports 487 888
Deaths Reported 154 118
Death Rate 31.6% 13.3%
Hospitalizations 264 364
Average Patient Age 49.6 yrs 57.0 yrs
% Female Patients 83.0% 50.1%
FDA Approval Date N/A Aug 20, 2020
Manufacturer N/A Dr. Reddy's Laboratories Inc.,
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued